Impact of the COVID-19 Pandemic on Neurodegenerative and Psychiatric Disorders
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neurodegenerative Diseases".
Deadline for manuscript submissions: closed (20 July 2022) | Viewed by 342
Special Issue Editor
2. Postgraduate Program in Medicine and Health, Faculty of Medicine of Bahia, Federal University of Bahia, Salvador, BA, Brazil
3. Department of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil
Interests: neurodegenerative diseases; psychiatric disorders; neuroimaging; neurobiology; neuroprogression; inflammation; biomarkers; brain mapping; tractography; neurocir-cuits; meta-analyses
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
COVID-19 has caused an increase in the number of neurological and psychiatric diseases. While the impact of the spread of coronavirus on the brain and mental illness is still being measured and reported in several studies, the brain health implications of situations like the one we are experiencing remain under investigation. The new SARS-CoV-2 affected brain risk and prognosis. Its management remains a challenge for healthcare professionals and patients around the world, especially in developing countries. This Special Issue of Brain Sciences will be dedicated to publishing the best articles that reflect the efforts and innovation to better diagnose, measure impact, and develop treatments and education for brain disease and related issues. In this Special Issue, we hope to bring together the best original and review articles on various aspects related to diagnosis, prevention, control, treatment, cost-effectiveness, epidemiology, education and other issues related to these very prevalent diseases. All submissions will be peer reviewed to ensure the quality and relevance of the manuscripts.
Dr. Leonardo Roever
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- cerebrovascular disease
- mental health
- epidemiology
- biomarkers
